Robert A Hauser

Robert A Hauser

UNVERIFIED PROFILE

Are you Robert A Hauser?   Register this Author

Register author
Robert A Hauser

Robert A Hauser

Publications by authors named "Robert A Hauser"

Are you Robert A Hauser?   Register this Author

100Publications

3486Reads

50Profile Views

Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey.

Neuropsychiatr Dis Treat 2019 5;15:2205-2212. Epub 2019 Aug 5.

Department of Neurology, USF Health Parkinson's Disease and Movement Disorders Center, Parkinson Foundation Center of Excellence, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/NDT.S213917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689087PMC
August 2019

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.

Nat Rev Drug Discov 2018 11 28;17(11):804-822. Epub 2018 Sep 28.

Centre d'Investigation Clinique CIC1436, Services de Neurologie et de Pharmacologie Clinique, Réseau NS-PARK/FCRIN et Centre COEN NeuroToul, CHU de Toulouse, INSERM, University of Toulouse 3, Toulouse, France.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nrd.2018.136
Publisher Site
http://dx.doi.org/10.1038/nrd.2018.136DOI Listing
November 2018

Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease.

Mov Disord Clin Pract 2018 Nov-Dec;5(6):627-634. Epub 2018 Nov 8.

Department of Neurology and Neurotherapeutics UT Southwestern Medical Center Dallas TX USA.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/mdc3.12695
Publisher Site
http://dx.doi.org/10.1002/mdc3.12695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277368PMC
November 2018

Help cure Parkinson's disease: please don't waste the Golden Year.

Authors:
Robert A Hauser

NPJ Parkinsons Dis 2018 25;4:29. Epub 2018 Sep 25.

University of South Florida, Tampa, FL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41531-018-0065-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156591PMC
September 2018

A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia.

Int J Neurosci 2018 Jul 17;128(7):619-626. Epub 2018 Jan 17.

h Methodist Neurological Institute , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00207454.2017.1406935DOI Listing
July 2018

The nosology of tardive syndromes.

J Neurol Sci 2018 06 6;389:10-16. Epub 2018 Feb 6.

Parkinson's Disease and Movement Disorders Center, Departments of Neurology, Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL 33613, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2018.02.008DOI Listing
June 2018

Tardive dyskinesia: Out of the shadows.

J Neurol Sci 2018 06 5;389:1-3. Epub 2018 Feb 5.

The Truong Neurosciences Institute, Fountain Valley, CA, United States; Department of Neurology, University of California, Riverside, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2018.02.009DOI Listing
June 2018

ADS-5102 (Amantadine) Extended Release for Levodopa-Induced Dyskinesia.

JAMA Neurol 2017 12;74(12):1507-1508

University of South Florida, Tampa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2017.3205DOI Listing
December 2017

Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's disease.

Int J Neurosci 2017 Oct 20;127(10):841-848. Epub 2016 Dec 20.

a School of Aging Studies University of South Florida , Tampa , FL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00207454.2016.1269088DOI Listing
October 2017

Valbenazine for the treatment of tardive dyskinesia.

Expert Opin Pharmacother 2017 Aug 2;18(12):1279-1287. Epub 2017 Aug 2.

b Department of Neurology , University of South Florida , Tampa , FL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1353078DOI Listing
August 2017

Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.

Neurology 2017 Jun 10;88(23):2198-2206. Epub 2017 May 10.

From the Institute of Neurology (F.S.), IRCCS San Raffaele, Rome, Italy; Departments of Clinical Pharmacology and Neurosciences (O.R.), Clinical Investigation Center CIC1436, NS-Park Clinical Research Network, NeuroToul Centre of Excellence in Neurodegeneration, INSERM, Toulouse University Hospital and Toulouse University, France; Parkinson's Disease and Movement Disorders Center (R.A.H.), USF Health-Byrd Institute, Tampa, FL; and Merck & Co., Inc. (S.H., A.T., R.C., T.W.H., P.S., C.L., D.M., D.J.H.), Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004003DOI Listing
June 2017

Design of a cluster-randomized minority recruitment trial: RECRUIT.

Clin Trials 2017 Jun 19;14(3):286-298. Epub 2017 Mar 19.

8 Department of Health Promotion and Behavioral Sciences, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774517690146DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448312PMC
June 2017

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.

Am J Psychiatry 2017 05 21;174(5):476-484. Epub 2017 Mar 21.

From the Departments of Neurology and Molecular Pharmacology and Physiology, University of South Florida, Tampa; the Department of Neurology, Emory University, Atlanta; the Department of Psychiatry, University of California, Los Angeles; University Hills Clinical Research, Irving, Tex.; the Department of Psychology, Long Island University, New York; and Neurocrine Biosciences, Inc., San Diego.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2017.16091037DOI Listing
May 2017

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study.

Neurology 2017 May 26;88(21):2003-2010. Epub 2017 Apr 26.

From the Cleveland Clinic (H.H.F.), Center for Neurological Restoration, Cleveland, OH; Emory University (S.A.F.), Atlanta, GA; University of South Florida Parkinson's Disease and Movement Disorders Center (R.A.H.), Tampa, FL; Baylor College of Medicine (J.J.-S.), Houston, TX; Methodist Neurological Institute (W.G.O.), Houston, TX; University of North Carolina School of Medicine (L.F.J.), Chapel Hill, NC; Northwestern University Feinberg School of Medicine (H.Y.M., D.B.), Chicago, IL; Yale School of Medicine (S.W.W.), New Haven, CT; University of Tennessee Health Science Center (M.S.L.), Memphis, TN; University of Utah Health Care (D.R.S.), Salt Lake City, UT; Banner Sun Health Research Institute (D.R.S.), Sun City, AZ; CSD Biostatistics (C.D.), Tucson, AZ; Teva Pharmaceutical Industries (M.D.D.), Frazer, PA; Teva Pharmaceuticals (D.S.), La Jolla, CA; and Georgetown University (K.E.A.), Washington, DC.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000003960DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440239PMC
May 2017

Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension.

Am J Cardiol 2017 Apr 6;119(7):1111-1115. Epub 2017 Jan 6.

Lundbeck LLC, Deerfield, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2016.11.066DOI Listing
April 2017

Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension.

Clin Neuropharmacol 2016 Sep-Oct;39(5):220-6

*Parkinson's Disease and Movement Disorders Center, University of South Florida Health, Byrd Institute, Tampa, FL; †Monash University, Melbourne, Australia; ‡Lundbeck, Deerfield, IL; and §Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028156PMC
http://dx.doi.org/10.1097/WNF.0000000000000168DOI Listing
January 2017

Communicating with participants during the conduct of multi-center clinical trials.

Clin Trials 2016 12 29;13(6):592-596. Epub 2016 Aug 29.

Center for Human Experimental Therapeutics, University of Rochester, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774516665596DOI Listing
December 2016

Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.

Parkinsonism Relat Disord 2016 12 8;33:127-133. Epub 2016 Oct 8.

Dept. of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2016.10.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091572PMC
December 2016

Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies.

Int J Neurosci 2016 Oct 18;126(10):942-6. Epub 2016 Mar 18.

c Teva Pharmaceuticals , Petah Tikva , Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00207454.2016.1154552DOI Listing
October 2016

Long-term effects of rasagiline and the natural history of treated Parkinson's disease.

Mov Disord 2016 10;31(10):1489-1496

Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26724DOI Listing
October 2016

Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.

Int J Neurosci 2016 18;126(1):20-4. Epub 2015 Aug 18.

c 3 Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00207454.2013.841685DOI Listing
September 2016

Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.

Mov Disord 2016 09 19;31(9):1366-72. Epub 2016 Jul 19.

Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26697DOI Listing
September 2016

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.

Lancet Neurol 2016 Aug;15(9):954-966

Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, University Health Network, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(16)30079-5DOI Listing
August 2016

Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension.

BMC Neurol 2016 Aug 18;16(1):143. Epub 2016 Aug 18.

Parkinson's Disease and Movement Disorders Center, University of South Florida, 4001 E Fletcher Ave, Tampa, FL, 33596, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-016-0665-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990877PMC
August 2016

Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.

Clin Neuropharmacol 2015 Sep-Oct;38(5):163-9

*Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; †Department of Biostatistics, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX; ‡Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA; §Department of Neurology, University of California, San Francisco, CA; ∥Department of Clinical Pharmacy and Neurology, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO; ¶Department of Neurology, University of South Florida, Tampa, FL; #Department of Pathology, Anatomy and Cell Biology, Parkinson's Disease Research Unit, Thomas Jefferson University, Philadelphia, PA; **Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, NY; ††Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL; ‡‡Parkinson's Disease Research Education and Clinical Center, San Francisco Veteran's Affairs Medical Center, San Francisco, CA; §§The Parkinson's and Movement Disorder Institute, Fountain Valley, CA; and ∥∥Singapore General Hospital, Singapore.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/clinicalneuropharm/2015/09000/C
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/WNF.0000000000000102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573899PMC
June 2016

Carbidopa levodopa enteral suspension.

Expert Opin Pharmacother 2015 23;16(18):2807-17. Epub 2015 Nov 23.

b Department of Neurology , Molecular Pharmacology and Physiology, University of South Florida , Tampa , FL 33613 , USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.2015.11
Publisher Site
http://dx.doi.org/10.1517/14656566.2015.1111336DOI Listing
June 2016

Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.

Mov Disord 2016 05 31;31(5):709-14. Epub 2016 Mar 31.

Teva Pharmaceuticals, Overland Park, Kansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26617DOI Listing
May 2016

A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia.

J Neurol 2016 Apr 25;263(4):772-80. Epub 2016 Feb 25.

School of Medicine, Johns Hopkins University, 600 N. Wolfe Street, Meyer 6-181B, Baltimore, MD, 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-016-8050-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826665PMC
April 2016

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Authors:
Kevin Michael Biglan Ira Shoulson Karl Kieburtz David Oakes Elise Kayson M Aileen Shinaman Hongwei Zhao Megan Romer Anne Young Steven Hersch Jack Penney Karen Marder Jane Paulsen Kimberly Quaid Eric Siemers Caroline Tanner William Mallonee Greg Suter Richard Dubinsky Carolyn Gray Martha Nance Scott Bundlie Dawn Radtke Sandra Kostyk Corrine Baic James Caress Francis Walker Victoria Hunt Christine O'Neill Sylvain Chouinard Stewart Factor Timothy Greenamyre Cathy Wood-Siverio Jody Corey-Bloom David Song Guerry Peavy Carol Moskowitz Melissa Wesson Ali Samii Thomas Bird Hillary Lipe Karen Blindauer Frederick Marshall Carol Zimmerman Jody Goldstein Diana Rosas Peter Novak John Caviness Charles Adler Amy Duffy Vicki Wheelock Teresa Tempkin David Richman Lauren Seeberger Roger Albin Kelvin L Chou Brad Racette Joel S Perlmutter Susan Perlman Yvette Bordelon Wayne Martin Marguerite Wieler Blair Leavitt Lynn Raymond Joji Decolongon Lorne Clarke Joseph Jankovic Christine Hunter Robert A Hauser Juan Sanchez-Ramos Sarah Furtado Oksana Suchowersky Mary Lou Klimek Mark Guttman Rustom Sethna Andrew Feigin Marie Cox Barbara Shannon Alan Percy Leon Dure Madaline Harrison William Johnson Donald Higgins Eric Molho Constance Nickerson Sharon Evans Douglas Hobson Carlos Singer Nestor Galvez-Jimenez Kathleen Shannon Cynthia Comella Christopher Ross Marie H Saint-Hilaire Claudia Testa Adam Rosenblatt Penelope Hogarth William Weiner Peter Como Rajeev Kumar Candace Cotto Julie Stout Alicia Brocht Arthur Watts Shirley Eberly Christine Weaver Tatiana Foroud James Gusella Marcy MacDonald Richard Myers Stanley Fahn Clifford Shults

JAMA Neurol 2016 Jan;73(1):102-10

Department of Neuroscience, University of California, San Diego, La Jolla.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2015.2736DOI Listing
January 2016

α-Synuclein in Parkinson's disease: getting to the core of the matter.

Authors:
Robert A Hauser

Lancet Neurol 2015 Aug 23;14(8):785-786. Epub 2015 Jun 23.

Departments of Neurology, Molecular Pharmacology and Physiology, University of South Florida Parkinson's Disease and Movement Disorders Center, National Parkinson Foundation Center of Excellence, Tampa, FL 33613, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(15)00136-2DOI Listing
August 2015

Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).

Mov Disord 2015 Apr 9;30(5):646-54. Epub 2014 Dec 9.

University of South Florida, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26086DOI Listing
April 2015

Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS.

Mov Disord 2015 Apr 27;30(4):589-92. Epub 2014 Dec 27.

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26124DOI Listing
April 2015

Initial choice of medication has little effect on short-term or long-term outcome for most patients with Parkinson's disease.

Authors:
Robert A Hauser

Evid Based Med 2015 Feb 18;20(1):17. Epub 2014 Dec 18.

Department of Neurology, University of South Florida, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ebmed-2014-110115DOI Listing
February 2015

Who is helping whom? Manuscript support and transfer of value.

Ann Neurol 2015 Feb 20;77(2):353-5. Epub 2015 Jan 20.

Department of Neurology, Temple University School of MedicineShriners Hospital Pediatric Research Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24352DOI Listing
February 2015

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes.

Alzheimers Res Ther 2014 8;6(5-8):67. Epub 2014 Oct 8.

Medical Affairs, GE Healthcare - Life Sciences, 101 Carnegie Center, Princeton NJ 08540, New Jersey, USA ; Presently: Novartis Consumer Health, Parsippany, New Jersey, USA ; Presently: Genpact Pharmalink, Short Hills, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13195-014-0067-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255542PMC
December 2014

Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A).

J Parkinsons Dis 2014 ;4(1):57-65

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-130259DOI Listing
October 2014

Peptidoglycan recognition protein genes and risk of Parkinson's disease.

Mov Disord 2014 Aug 17;29(9):1171-80. Epub 2014 May 17.

San Francisco Veterans Affairs Medical Center, San Francisco, California, USA; University of California, San Francisco, San Francisco, California, USA; The Parkinson's Institute, Sunnyvale, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25895DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777298PMC
August 2014

Mutant huntingtin is present in neuronal grafts in Huntington disease patients.

Ann Neurol 2014 Jul 6;76(1):31-42. Epub 2014 Jun 6.

Centre Hospitalier Universitaire de Québec Research Center; Departments of Psychiatry and Neurosciences.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ana.24174
Publisher Site
http://dx.doi.org/10.1002/ana.24174DOI Listing
July 2014

Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease.

Mov Disord 2014 Jul 11;29(8):1028-34. Epub 2014 Jun 11.

Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25877DOI Listing
July 2014

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Authors:
M Flint Beal David Oakes Ira Shoulson Claire Henchcliffe Wendy R Galpern Richard Haas Jorge L Juncos John G Nutt Tiffini Smith Voss Bernard Ravina Clifford M Shults Karen Helles Victoria Snively Mark F Lew Brian Griebner Arthur Watts Shan Gao Emmanuelle Pourcher Louisette Bond Katie Kompoliti Pinky Agarwal Cherissa Sia Mandar Jog Linda Cole Munira Sultana Roger Kurlan Irene Richard Cheryl Deeley Cheryl H Waters Angel Figueroa Ani Arkun Matthew Brodsky William G Ondo Christine B Hunter Joohi Jimenez-Shahed Alicia Palao Janis M Miyasaki Julie So James Tetrud Liza Reys Katharine Smith Carlos Singer Anita Blenke David S Russell Candace Cotto Joseph H Friedman Margaret Lannon Lin Zhang Edward Drasby Rajeev Kumar Thyagarajan Subramanian Donna Stuppy Ford David A Grimes Diane Cote Jennifer Conway Andrew D Siderowf Marian Leslie Evatt Barbara Sommerfeld Abraham N Lieberman Michael S Okun Ramon L Rodriguez Stacy Merritt Camille Louise Swartz W R Wayne Martin Pamela King Natividad Stover Stephanie Guthrie Ray L Watts Anwar Ahmed Hubert H Fernandez Adrienna Winters Zoltan Mari Ted M Dawson Becky Dunlop Andrew S Feigin Barbara Shannon Melissa Jill Nirenberg Mattson Ogg Samuel A Ellias Cathi-Ann Thomas Karen Frei Ivan Bodis-Wollner Sofya Glazman Thomas Mayer Robert A Hauser Rajesh Pahwa April Langhammer Ranjit Ranawaya Lorelei Derwent Kapil D Sethi Buff Farrow Rajan Prakash Irene Litvan Annette Robinson Alok Sahay Maureen Gartner Vanessa K Hinson Samuel Markind Melisa Pelikan Joel S Perlmutter Johanna Hartlein Eric Molho Sharon Evans Charles H Adler Amy Duffy Marlene Lind Lawrence Elmer Kathy Davis Julia Spears Stephanie Wilson Maureen A Leehey Neal Hermanowicz Shari Niswonger Holly A Shill Sanja Obradov Alex Rajput Marilyn Cowper Stephanie Lessig David Song Deborah Fontaine Cindy Zadikoff Karen Williams Karen A Blindauer Jo Bergholte Clara Schindler Propsom Mark A Stacy Joanne Field Dragos Mihaila Mark Chilton Ergun Y Uc Jeri Sieren David K Simon Lauren Kraics Althea Silver James T Boyd Robert W Hamill Christopher Ingvoldstad Jennifer Young Karen Thomas Sandra K Kostyk Joanne Wojcieszek Ronald F Pfeiffer Michel Panisset Monica Beland Stephen G Reich Michelle Cines Nancy Zappala Jean Rivest Richard Zweig L Pepper Lumina Colette Lynn Hilliard Stephen Grill Marye Kellermann Paul Tuite Susan Rolandelli Un Jung Kang Joan Young Jayaraman Rao Maureen M Cook Lawrence Severt Karyn Boyar

JAMA Neurol 2014 May;71(5):543-52

Department of Neurology, Beth Israel Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.131DOI Listing
May 2014

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.

Parkinsonism Relat Disord 2014 Feb 5;20(2):142-8. Epub 2013 Sep 5.

Impax Pharmaceuticals, Hayward, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2013.08.017DOI Listing
February 2014

Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease.

Mov Disord 2014 Jan 13;29(1):75-82. Epub 2013 Dec 13.

Department of Neurology, Henry Ford Hospital, West Bloomfield, Michigan, USA; Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25742DOI Listing
January 2014

An update on Parkinson's disease: improving patient outcomes.

Am J Med 2014 Jan;127(1):S3

Associate Professor of Neurology, Director, The Johns Hopkins Parkinson's Disease and Movement Disorders Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2013.06.016DOI Listing
January 2014

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.

J Neurol Neurosurg Psychiatry 2013 Nov 13;84(11):1288-95. Epub 2013 Mar 13.

Department of Clinical Neurology, National Parkinson's Foundation International Centre of Excellence, Nottingham University Hospitals NHS Trust and University of Nottingham, , Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2012-304436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812862PMC
November 2013

Randomized trial of cognitive speed of processing training in Parkinson disease.

Neurology 2013 Oct 6;81(15):1284-90. Epub 2013 Sep 6.

From the School of Aging Studies (J.D.E., E.G.V.) and Department of Neurology (R.A.H., T.A.Z.), University of South Florida, Tampa; Department of Human Development and Family Science (M.L.O.), North Dakota State University, Fargo; Department of Neurology (E.Y.U.), University of Iowa, Iowa City; and Neurology Service (E.Y.U.), Veterans Affairs Medical Center, Iowa City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e3182a823baDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806923PMC
October 2013

PROUD stands tall: delayed-start studies in Parkinson's disease.

Authors:
Robert A Hauser

Lancet Neurol 2013 Aug 31;12(8):728-9. Epub 2013 May 31.

University of South Florida, Parkinson's Disease and Movement Disorders Center, National Parkinson Foundation Center of Excellence, 4001 E Fletcher Avenue, Tampa, FL 33613, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(13)70121-2DOI Listing
August 2013

Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia.

Clin Neuropharmacol 2012 Sep-Oct;35(5):208-14

Department of Neurology, Vanderbilt University School of Medicine, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0b013e31826538c7DOI Listing
July 2013

Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.

Mov Disord 2013 Jun 15;28(6):817-20. Epub 2013 Apr 15.

Emory University School of Medicine, Department of Neurology, Atlanta, Georgia 30329, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25395DOI Listing
June 2013

Which dyskinesia scale best detects treatment response?

Mov Disord 2013 Mar 6;28(3):341-6. Epub 2013 Feb 6.

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25321DOI Listing
March 2013

AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies.

J Neural Transm (Vienna) 2013 Feb 10;120(2):299-307. Epub 2012 Aug 10.

Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, Byrd Institute, University of South Florida, 4001 E. Fletcher Ave, 6th Floor, Tampa, FL 33613, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00702-012-0872-1
Publisher Site
http://dx.doi.org/10.1007/s00702-012-0872-1DOI Listing
February 2013

Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.

Brain 2013 Feb 31;136(Pt 2):433-43. Epub 2013 Jan 31.

Centre de Recherche du CHUQ, Axe Neurosciences, Boulevard Laurier, Québec, QC G1V 4G2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/aws359DOI Listing
February 2013

Future treatments for Parkinson's disease: surfing the PD pipeline.

Authors:
Robert A Hauser

Int J Neurosci 2011 ;121 Suppl 2:53-62

Department of Neurology, College of Medicine, University of South Florida, Tampa, Florida 33606, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00207454.2011.620195DOI Listing
August 2012

A(2A) Receptor Antagonism and Dyskinesia in Parkinson's Disease.

Parkinsons Dis 2012 17;2012:489853. Epub 2012 Jun 17.

Department of Biomedical Sciences, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/489853DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382949PMC
August 2012

The UPDRS-8: a brief clinical assessment scale for Parkinson's disease.

Int J Neurosci 2012 Jul 23;122(7):333-7. Epub 2012 Feb 23.

Departments of Neurology, Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00207454.2012.657381DOI Listing
July 2012

Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study).

Neurology 2012 Jul 27;79(2):163-9. Epub 2012 Jun 27.

Departments of Neurology, Henry Ford Hospital, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e31825f0451DOI Listing
July 2012

IPX066: a novel carbidopa-levodopa extended-release formulation.

Authors:
Robert A Hauser

Expert Rev Neurother 2012 Feb;12(2):133-40

University of South Florida Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, Byrd Institute, 4001 E. Fletcher Ave, 6th Floor, Tampa, FL 33613, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ern.11.195DOI Listing
February 2012

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.

Mov Disord 2011 Oct 13;26(12):2246-52. Epub 2011 Jul 13.

Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23861DOI Listing
October 2011

Pardoprunox in early Parkinson's disease: results from 2 large, randomized double-blind trials.

Mov Disord 2011 Jul 3;26(8):1464-76. Epub 2011 May 3.

Laboratório de Farmacologia Clinica e Terapêutica e Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Edifício do Hospital de Santa Maria, Lisboa, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23590DOI Listing
July 2011